Post-Surgical Blood Clot Study Stirs Controversy
He adds, "I would feel very uncomfortable using the rates from this study in counseling a patient, because I think they (the authors) underestimate the true risk."
Heit says that the other problem with the analysis these researchers produced was that most of the data came from randomized controlled trials, which are structured to exclude patients who are older, and sicker and have multiple co-morbidities, the very patients who might be more likely to have higher rates of VTE.
Additionally, the researchers' report assumed patients remained in the hospital for up to 14 weeks, when today, most patients with hip or knee replacement surgery are discharged after the third or fourth postoperative day, Heit says.
The issue is further confused by statements from the American Academy of Orthopaedic Surgeons, which says that for patients with total hip replacement, 7% develop deep vein thrombosis and .3% develop a pulmonary embolism within 90 days of surgery. For total knee replacement patients, .9% develop deep vein thrombosis and .3% develop a pulmonary embolism within 90 days of surgery.
Heit says that the issue remains extremely controversial "because there's such a lack of good data on what is most effective, and what's most safe."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- Ratcheting Up Patient Experience Has a Downside
- 'Mega Boards' Could be Rural Healthcare Disruptor
- Narrow Networks Enjoying a Resurgence
- Physicians Trained in High-Cost Regions Spend More
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- HL20: Lee Aase—Who's Behind @MayoClinic
- Christmas Tree Syndrome Season Underway
- HL20: Tom X. Lee, MD—Reinventing Primary Care
- Population Health Starts with Ending Hunger
- HL20: José Ramón Fernández-Peña, MD, MPA—A Welcoming Approach